Qiagen is a holding company. Through its subsidiaries, Co. is a global provider of Sample to Insight solutions that enable customers to gain molecular insights from samples containing the building blocks of life. Co.'s sample technologies isolate and process deoxyribonucleic acid, ribonucleic acid and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in workflows. Co. provides solutions to customers in Molecular Diagnostics and Life Sciences.